These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1647043)

  • 1. Genetically engineered herpesvirus vaccines. Accomplishments in pigs and prospects in humans.
    Kit S; Kit M
    Prog Med Virol; 1991; 38():128-66. PubMed ID: 1647043
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 3. Engineered human vaccines.
    Sandhu JS
    Crit Rev Biotechnol; 1994; 14(1):1-27. PubMed ID: 8187202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene cloning to study viral antigens: prospects for novel influenza and rotavirus vaccines.
    Both GW; Jennings PA
    Prog Vet Microbiol Immunol; 1987; 3():179-213. PubMed ID: 2856220
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic engineering of the pseudorabies virus genome to construct live vaccines.
    Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC
    J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
    Whelan SP; Evans D; Almond JW
    Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the construction of safer and more versatile pseudorabies virus vaccines.
    Mettenleiter TC
    Dev Biol Stand; 1995; 84():83-7. PubMed ID: 7796971
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.
    Tartaglia J; Cox WI; Pincus S; Paoletti E
    Dev Biol Stand; 1994; 82():125-9. PubMed ID: 7958466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of insect cell gene expression in pharmaceutical research.
    Thomsen DR; Meyer AL; Post LE
    Bioprocess Technol; 1993; 17():105-38. PubMed ID: 7764046
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences with the first field release of genetically engineered viruses.
    Possee RD; Cameron IR; Allen CJ; Bishop DH
    Schriftenr Ver Wasser Boden Lufthyg; 1988; 78():165-86. PubMed ID: 3074479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the development of vaccines against Aujeszky's disease].
    Mettenleiter TC
    Tierarztl Prax; 1995 Dec; 23(6):570-4. PubMed ID: 8585074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to vaccine development against HBV.
    Thanavala Y
    J Biotechnol; 1996 Jan; 44(1-3):67-73. PubMed ID: 8717388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of translational control elements as a new approach to design of attenuated picornavirus strains.
    Agol VI; Pilipenko EV; Slobodskaya OR
    J Biotechnol; 1996 Jan; 44(1-3):119-28. PubMed ID: 8717395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of genetically engineered viral vaccines of poultry.
    Carlson JH
    Avian Dis; 1986; 30(1):24-7. PubMed ID: 3460565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engerix-B, a new genetically engineered hepatitis B vaccine, approved by FDA.
    Oncology (Williston Park); 1989 Dec; 3(12):44. PubMed ID: 2534905
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
    Cook DR; Hill HT; Kinker DR
    Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus.
    Ruiz-Gonzalvo F; Rodríguez F; Escribano JM
    Virology; 1996 Apr; 218(1):285-9. PubMed ID: 8615037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.